HomePANG • BME
add
Pangaea Oncology SA
Previous close
€1.70
Year range
€1.64 - €1.80
Market cap
58.50M EUR
Avg Volume
203.00
P/E ratio
-
Dividend yield
-
Primary exchange
BME
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 3.77M | — |
Operating expense | 4.07M | — |
Net income | -799.85K | — |
Net profit margin | -21.19 | — |
Earnings per share | — | — |
EBITDA | -457.21K | — |
Effective tax rate | 5.56% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.86M | — |
Total assets | 26.87M | — |
Total liabilities | 9.95M | — |
Total equity | 16.92M | — |
Shares outstanding | 30.43M | — |
Price to book | 3.21 | — |
Return on assets | -7.25% | — |
Return on capital | -9.35% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -799.85K | — |
Cash from operations | -588.35K | — |
Cash from investing | -26.07K | — |
Cash from financing | 207.30K | — |
Net change in cash | -407.12K | — |
Free cash flow | 22.71K | — |
About
Founded
2006
Website
Employees
165
